Global Sourcing of Medicines for Australian Healthcare Providers
HL Pharma supports hospitals, health services and specialist clinics across Australia when standard pharmaceutical supply routes cannot meet clinical needs. Alongside this, we support sponsors and manufacturers as an APAC depot, Sponsor and Importer of Record, providing compliant access pathways into Australia.
We focus on global sourcing of medicines for Australian healthcare, helping care teams manage medicine shortages, access specialist or rare therapies and support patients who depend on complex or long‑term treatments.
For veterinary organisations, see Managing Veterinary Medicine Shortages in Australia.
We operate within Therapeutic Goods Administration (TGA) frameworks, using mechanisms such as Section 19A, the Special Access Scheme (SAS) and the Authorised Prescriber scheme to enable controlled access to overseas‑registered or unregistered medicines when no suitable locally registered alternative is available.
These sourcing and supply activities are supported by HL Pharma’s certified quality and distribution framework, which links global procurement to our Melbourne-based APAC depot for temperature-controlled pharmaceutical storage and nationwide distribution. Our ISO 9001:2015-certified quality management system and PIC/S GDP-aligned distribution practices provide documented procedures, risk-based controls and complete traceability from initial enquiry through to final delivery.
Who We Support
HL Pharma partners with healthcare organisations, sponsors and manufacturers that need a compliant medicines sourcing and supply specialist rather than a general wholesaler. Our capabilities span the entire compliant supply pathway, from global procurement and importation through to validated temperature-controlled storage and nationwide distribution, with each step supported by document quality assurance, batch and expiry tracking and audit-ready record management
Public, private and regional hospital and health service pharmacy departments
State and territory health departments, central procurement units and tender teams
Specialist clinics and day hospitals in oncology, haematology, neurology, pain and palliative care
Clinical trial units and research groups needing comparator, rescue or extension medicines
Community and speciality pharmacies supporting rare disease and complex therapy cohorts
We assist with both ongoing access, where a medicine is consistently difficult to obtain, and exceptional access for individual patients or small groups when standard supply routes are not sufficient.
Sourcing Global Medicines and Medical Devices
At HL Pharma, regulatory integrity is at the core of every sourcing decision. Our purpose is to ensure that healthcare providers across Australia have dependable access to global medicines and medical devices, including products in short supply, discontinued therapies, and treatments that are standard of care overseas but not registered locally. Access is always arranged within TGA frameworks, ensuring that clinicians and governance committees can rely on a clear and defensible pathway.
Our medicines sourcing capability spans the full pathway, from identifying suitable products and verifying overseas manufacturers through to importation, validated temperature-controlled storage and nationwide distribution across Australia. Each request is assessed against the appropriate TGA access mechanism, such as Section 19A, SAS or Authorised Prescriber, and supported by document quality assurance, batch and expiry tracking and audit-ready records, so hospitals and clinics can rely on a transparent and compliant supply chain for every medicine we provide.
Contact us to discuss compliant global sourcing and secure supply pathways for licensed and unlicensed medicines for Australian healthcare providers.